Scope Fluidics Spolka Akcyjna (WAR:SCP) Total Stockholders Equity: zł148.96 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:SCP Scope Fluidics Spolka Akcyjna WAR:SCP
47 GF Score
Price zł131.40
GF Value zł125.15
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Scope Fluidics Spolka Akcyjna Total Stockholders Equity?

Scope Fluidics Spolka Akcyjna WAR:SCP -1.94% 47 Total Stockholders Equity is zł148.96 Mil as of Mar. 2026. GuruFocus rates WAR:SCP with a GF Score™ of 47/100 and a GF Value™ of zł125.15 (Fairly Valued). The stock has 4 warning signs investors should review.

Scope Fluidics Spolka Akcyjna's Total Stockholders Equity for the quarter that ended in Mar. 2026 was zł148.96 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Scope Fluidics Spolka Akcyjna's Book Value per Share for the quarter that ended in Mar. 2026 was zł47.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Scope Fluidics Spolka Akcyjna's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.02.

Scope Fluidics Spolka Akcyjna  (WAR:SCP) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Scope Fluidics Spolka Akcyjna's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(148.958-0)/3.168
=47.02

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Scope Fluidics Spolka Akcyjna's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1.591 + 0.707) / 148.958
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scope Fluidics Spolka Akcyjna Total Stockholders Equity Related Terms

Scope Fluidics Spolka Akcyjna Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Scope Fluidics Spolka Akcyjna's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scope Fluidics Spolka Akcyjna Total Stockholders Equity Chart

Scope Fluidics Spolka Akcyjna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.74 332.97 80.93 146.35 162.43

Scope Fluidics Spolka Akcyjna Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 135.35 126.80 115.43 162.43 148.96
WAR:SCP
47GF Score
Scope Fluidics Spolka Akcyjna WAR:SCP
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of zł148.96 Mil mean?
Scope Fluidics Spolka Akcyjna (WAR:SCP) has a Total Stockholders Equity of zł148.96 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Scope Fluidics Spolka Akcyjna and its competitors.
Is Scope Fluidics Spolka Akcyjna's Total Stockholders Equity too high?
Scope Fluidics Spolka Akcyjna's current Total Stockholders Equity is zł148.96 Mil. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's Total Stockholders Equity compare to TMO and DHR?
Scope Fluidics Spolka Akcyjna's Total Stockholders Equity of zł148.96 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Diagnostics & Research company?
A good Total Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Scope Fluidics Spolka Akcyjna and its competitors. Scope Fluidics Spolka Akcyjna's current Total Stockholders Equity is zł148.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna (WAR:SCP) is currently considered Fairly Valued. The stock's GF Value™ is zł125.15, compared to a current price of zł131.40 — trading 5% above its estimated fair value. The current Total Stockholders Equity is zł148.96 Mil. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (WAR:SCP), the current Total Stockholders Equity is zł148.96 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scope Fluidics Spolka Akcyjna (WAR:SCP) Overvalued in 2026?

Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be overvalued. The current stock price of zł131.40 is trading 5% above its estimated GF Value™ of zł125.15. GuruFocus considers Scope Fluidics Spolka Akcyjna to be Fairly Valued.

Key valuation signals for WAR:SCP:

  • Total Stockholders Equity: zł148.96 Mil
  • GF Value™: zł125.15 vs. price of zł131.40 (5% above fair value)
  • GF Score™: 47/100 with 4 warning signs

No single metric tells the full story. See the WAR:SCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Scope Fluidics Spolka Akcyjna Business Description

Other Exchanges S84:Germany
Address Duchnicka 3, Build 16, Entrance A, Warsaw, POL, 01-796
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
47GF Score

Get the complete analysis for WAR:SCP

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł131.40
Price
zł125.15
GF Value